D-2-hydroxyglutaric aciduria: Further clinical delineation

M. S. Van Der Knaap, C. Jakobs, G. F. Hoffmann, M. Duran, A. C. Muntau, S. Schweitzer, R. I. Kelley, F. Parrot-Roulaud, J. Amiel, P. De Lonlay, D. Rabier, O. Eeg-Olofsson

Research output: Contribution to journalArticle

Abstract

It has recently been recognized that D-2-hydroxyglutaric aciduria is a distinct neurometabolic disorder with a severe and a mild phenotype. Whereas the clinical and neuroimaging findings of the severe phenotype were homogeneous among the patients, the findings in the mild phenotype were much more variable, leaving the clinical picture poorly defined. We were able to collect the clinical, biochemical and neuroimaging data on an additional 8 patients with D-2-hydroxyglutaric aciduria, 4 with the severe and 4 with the mild phenotype. With the new information, it becomes clear that the mild phenotype shares the essential characteristics of the severe phenotype. The most frequent findings, regardless of the clinical phenotype, are epilepsy, hypotonia and psychomotor retardation. Additional findings, mainly occurring in the severe phenotype, are episodic vomiting, cardiomyopathy, inspiratory stridor and apnoeas. The most consistent MRI finding is enlargement of the lateral ventricles, occipital more than frontal. Regardless of the clinical phenotype, early MRI shows in addition subependymal cysts and signs of delayed cerebral maturation. Later MRI may reveal multifocal cerebral white-matter abnormalities. Two patients had vascular abnormalities, but it is as yet unclear whether these are related to D-2-hydroxyglutaric aciduria or are incidental findings.

Original languageEnglish (US)
Pages (from-to)404-413
Number of pages10
JournalJournal of Inherited Metabolic Disease
Volume22
Issue number4
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Phenotype
Neuroimaging
Complex Partial Epilepsy
2-Hydroxyglutaricaciduria
Muscle Hypotonia
Incidental Findings
Lateral Ventricles
Respiratory Sounds
Apnea
Cardiomyopathies
Vomiting
Blood Vessels
Cysts

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Endocrinology

Cite this

Van Der Knaap, M. S., Jakobs, C., Hoffmann, G. F., Duran, M., Muntau, A. C., Schweitzer, S., ... Eeg-Olofsson, O. (1999). D-2-hydroxyglutaric aciduria: Further clinical delineation. Journal of Inherited Metabolic Disease, 22(4), 404-413. https://doi.org/10.1023/A:1005548005393

D-2-hydroxyglutaric aciduria : Further clinical delineation. / Van Der Knaap, M. S.; Jakobs, C.; Hoffmann, G. F.; Duran, M.; Muntau, A. C.; Schweitzer, S.; Kelley, R. I.; Parrot-Roulaud, F.; Amiel, J.; De Lonlay, P.; Rabier, D.; Eeg-Olofsson, O.

In: Journal of Inherited Metabolic Disease, Vol. 22, No. 4, 1999, p. 404-413.

Research output: Contribution to journalArticle

Van Der Knaap, MS, Jakobs, C, Hoffmann, GF, Duran, M, Muntau, AC, Schweitzer, S, Kelley, RI, Parrot-Roulaud, F, Amiel, J, De Lonlay, P, Rabier, D & Eeg-Olofsson, O 1999, 'D-2-hydroxyglutaric aciduria: Further clinical delineation', Journal of Inherited Metabolic Disease, vol. 22, no. 4, pp. 404-413. https://doi.org/10.1023/A:1005548005393
Van Der Knaap MS, Jakobs C, Hoffmann GF, Duran M, Muntau AC, Schweitzer S et al. D-2-hydroxyglutaric aciduria: Further clinical delineation. Journal of Inherited Metabolic Disease. 1999;22(4):404-413. https://doi.org/10.1023/A:1005548005393
Van Der Knaap, M. S. ; Jakobs, C. ; Hoffmann, G. F. ; Duran, M. ; Muntau, A. C. ; Schweitzer, S. ; Kelley, R. I. ; Parrot-Roulaud, F. ; Amiel, J. ; De Lonlay, P. ; Rabier, D. ; Eeg-Olofsson, O. / D-2-hydroxyglutaric aciduria : Further clinical delineation. In: Journal of Inherited Metabolic Disease. 1999 ; Vol. 22, No. 4. pp. 404-413.
@article{845d20f2eb0049ff80fc4dd4be4f4a10,
title = "D-2-hydroxyglutaric aciduria: Further clinical delineation",
abstract = "It has recently been recognized that D-2-hydroxyglutaric aciduria is a distinct neurometabolic disorder with a severe and a mild phenotype. Whereas the clinical and neuroimaging findings of the severe phenotype were homogeneous among the patients, the findings in the mild phenotype were much more variable, leaving the clinical picture poorly defined. We were able to collect the clinical, biochemical and neuroimaging data on an additional 8 patients with D-2-hydroxyglutaric aciduria, 4 with the severe and 4 with the mild phenotype. With the new information, it becomes clear that the mild phenotype shares the essential characteristics of the severe phenotype. The most frequent findings, regardless of the clinical phenotype, are epilepsy, hypotonia and psychomotor retardation. Additional findings, mainly occurring in the severe phenotype, are episodic vomiting, cardiomyopathy, inspiratory stridor and apnoeas. The most consistent MRI finding is enlargement of the lateral ventricles, occipital more than frontal. Regardless of the clinical phenotype, early MRI shows in addition subependymal cysts and signs of delayed cerebral maturation. Later MRI may reveal multifocal cerebral white-matter abnormalities. Two patients had vascular abnormalities, but it is as yet unclear whether these are related to D-2-hydroxyglutaric aciduria or are incidental findings.",
author = "{Van Der Knaap}, {M. S.} and C. Jakobs and Hoffmann, {G. F.} and M. Duran and Muntau, {A. C.} and S. Schweitzer and Kelley, {R. I.} and F. Parrot-Roulaud and J. Amiel and {De Lonlay}, P. and D. Rabier and O. Eeg-Olofsson",
year = "1999",
doi = "10.1023/A:1005548005393",
language = "English (US)",
volume = "22",
pages = "404--413",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - D-2-hydroxyglutaric aciduria

T2 - Further clinical delineation

AU - Van Der Knaap, M. S.

AU - Jakobs, C.

AU - Hoffmann, G. F.

AU - Duran, M.

AU - Muntau, A. C.

AU - Schweitzer, S.

AU - Kelley, R. I.

AU - Parrot-Roulaud, F.

AU - Amiel, J.

AU - De Lonlay, P.

AU - Rabier, D.

AU - Eeg-Olofsson, O.

PY - 1999

Y1 - 1999

N2 - It has recently been recognized that D-2-hydroxyglutaric aciduria is a distinct neurometabolic disorder with a severe and a mild phenotype. Whereas the clinical and neuroimaging findings of the severe phenotype were homogeneous among the patients, the findings in the mild phenotype were much more variable, leaving the clinical picture poorly defined. We were able to collect the clinical, biochemical and neuroimaging data on an additional 8 patients with D-2-hydroxyglutaric aciduria, 4 with the severe and 4 with the mild phenotype. With the new information, it becomes clear that the mild phenotype shares the essential characteristics of the severe phenotype. The most frequent findings, regardless of the clinical phenotype, are epilepsy, hypotonia and psychomotor retardation. Additional findings, mainly occurring in the severe phenotype, are episodic vomiting, cardiomyopathy, inspiratory stridor and apnoeas. The most consistent MRI finding is enlargement of the lateral ventricles, occipital more than frontal. Regardless of the clinical phenotype, early MRI shows in addition subependymal cysts and signs of delayed cerebral maturation. Later MRI may reveal multifocal cerebral white-matter abnormalities. Two patients had vascular abnormalities, but it is as yet unclear whether these are related to D-2-hydroxyglutaric aciduria or are incidental findings.

AB - It has recently been recognized that D-2-hydroxyglutaric aciduria is a distinct neurometabolic disorder with a severe and a mild phenotype. Whereas the clinical and neuroimaging findings of the severe phenotype were homogeneous among the patients, the findings in the mild phenotype were much more variable, leaving the clinical picture poorly defined. We were able to collect the clinical, biochemical and neuroimaging data on an additional 8 patients with D-2-hydroxyglutaric aciduria, 4 with the severe and 4 with the mild phenotype. With the new information, it becomes clear that the mild phenotype shares the essential characteristics of the severe phenotype. The most frequent findings, regardless of the clinical phenotype, are epilepsy, hypotonia and psychomotor retardation. Additional findings, mainly occurring in the severe phenotype, are episodic vomiting, cardiomyopathy, inspiratory stridor and apnoeas. The most consistent MRI finding is enlargement of the lateral ventricles, occipital more than frontal. Regardless of the clinical phenotype, early MRI shows in addition subependymal cysts and signs of delayed cerebral maturation. Later MRI may reveal multifocal cerebral white-matter abnormalities. Two patients had vascular abnormalities, but it is as yet unclear whether these are related to D-2-hydroxyglutaric aciduria or are incidental findings.

UR - http://www.scopus.com/inward/record.url?scp=0032969671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032969671&partnerID=8YFLogxK

U2 - 10.1023/A:1005548005393

DO - 10.1023/A:1005548005393

M3 - Article

C2 - 10407777

AN - SCOPUS:0032969671

VL - 22

SP - 404

EP - 413

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 4

ER -